Adverse Drug Reaction
Public health advisory for Trasylol issued by U.S. FDA
Published in Blood Weekly, March 23rd, 2006
The U.S. Food & Drug Administration (FDA) has issued a public health advisory alerting doctors who perform heart bypass surgery, and their patients, that Trasyolol (aprotinin injection), a drug used to prevent blood loss during surgery, has been linked in two scientific publications to higher risks of serious side effects including kidney problems, heart attacks, and strokes in patients who undergo artery bypass graft surgery.
"FDA is conducting a thorough evaluation of the safety profile for this drug in light of the recent publications," said Dr. Steven Galson, director of FDA's Center for Drug Evaluation and Research. "We're working to evaluate the potential risks...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2006-03-23)
More Articles from Blood Weekly
- Arthroplasty
Knee replacement postoperative unwashed shed blood use does not alter immunosuppression - Blood Safety
Risk of variant CJD transmission from blood products decreased in U.K. - Blood Safety
Sulfadoxine-pyrimethamine added to donor blood eradicates transfusion-induced malaria - Cord Blood
Cord blood stem cells clonogenic capacity not impaired by cryopreservation - Tissue Engineering
Functional corneal endothelial cell sheets fabricated for ocular surgery and repair - Allergy & Immunology
ImmunoCAP Phadiatop Infant allergy test detects IgE sensitization in 2-year-olds - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
